{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-028800","form_type":"8-K","ticker":"ADMA","cik":"0001368514","company_name":"ADMA BIOLOGICS, INC.","filed_at":"2024-06-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.113032+00:00","generated_at":"2026-06-01T06:29:19.853088+00:00","sec_items":["5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"ADMA Biologics shareholders elect three Class II directors and ratify auditor at 2024 annual meeting","bullets":["Steven A. Elms, Adam S. Grossman, Young T. Kwon elected as Class II directors with 71%, 97%, 98% of votes cast excluding broker non-votes.","Ratification of CohnReznick LLP as independent auditor for FY2024 approved with 184.5M for, 2.0M against, 0.2M abstain.","Annual meeting quorum achieved with 186.7M shares represented out of 231.8M outstanding (80.5% of shares)."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-028800","json":"https://secwatch.observer/filing/0001140361-24-028800.json","markdown":"https://secwatch.observer/filing/0001140361-24-028800.md","text":"https://secwatch.observer/filing/0001140361-24-028800.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1368514/000114036124028800/0001140361-24-028800-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1368514/000114036124028800/ef20030555_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T06:29:19.853088+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}